Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.76 USD | +3.28% | +0.68% | -28.40% |
Financials (USD)
Sales 2024 * | 279M | Sales 2025 * | 322M | Capitalization | 601M |
---|---|---|---|---|---|
Net income 2024 * | -69M | Net income 2025 * | -58M | EV / Sales 2024 * | -0.71 x |
Net cash position 2024 * | 800M | Net cash position 2025 * | 755M | EV / Sales 2025 * | -0.48 x |
P/E ratio 2024 * |
-8.7
x | P/E ratio 2025 * |
-10.7
x | Employees | 1,184 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 61.71% |
Latest transcript on Fulgent Genetics, Inc.
1 day | +3.28% | ||
1 week | +0.68% | ||
Current month | -4.61% | ||
1 month | -5.13% | ||
3 months | -21.11% | ||
6 months | -12.44% | ||
Current year | -28.40% |
Managers | Title | Age | Since |
---|---|---|---|
Ming Hsieh
CEO | Chief Executive Officer | 68 | 16-05-12 |
James Xie
FOU | Founder | 58 | 16-05-12 |
Paul Kim
DFI | Director of Finance/CFO | 56 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ming Hsieh
CEO | Chief Executive Officer | 68 | 16-05-12 |
Linda Marsh
BRD | Director/Board Member | 74 | 19-07-31 |
Regina Groves
BRD | Director/Board Member | 66 | 23-01-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.30% | 27 M€ | -5.03% | - | |
0.26% | 29 M€ | -4.33% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 20.7 | +2.99% | 26 480 |
24-04-26 | 20.1 | +0.35% | 77,988 |
24-04-25 | 20.03 | -3.42% | 184,148 |
24-04-24 | 20.74 | +0.48% | 152,597 |
24-04-23 | 20.64 | +0.39% | 144,249 |
Delayed Quote Nasdaq, April 29, 2024 at 10:37 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.40% | 601M | |
-16.58% | 8.25B | |
+41.03% | 3.58B | |
-39.11% | 2.46B | |
-7.71% | 2.46B | |
-8.95% | 2.38B | |
-6.55% | 1.81B | |
-19.73% | 1.55B | |
-40.66% | 1.21B | |
+7.56% | 1.11B |
- Stock Market
- Equities
- FLGT Stock